Patrick Aebischer

Patrick joined +ND Capital in our Lausanne office in 2017 and is currently a board member of Arctos Medical and Amazentis.

Prior to this, he was President of the Swiss Federal Institute of Technology (EPFL) for 16 years, which was transformed into a world-class science and technology university under his leadership. He has co-founded three biotechnology companies, and currently sits on the board of Nestlé and Logitech. He is also a former board member of Lonza. He chairs the advisory board of the Novartis Venture Fund, and continues to serve as an advisor to a number of private companies.

Patrick was trained as an MD and Neuroscientist at the University of Geneva and Fribourg in Switzerland. He has been a Professor at Brown University and the Lausanne University Hospital (CHUV), where he focused on cell and gene therapy approaches for the treatment of neurodegenerative diseases. He is a fellow of the American Institute for Medical and Biological Engineering and the Swiss Academy of Medical Sciences.